New Research Unveils Pathways for Autoimmune Treatments
Researchers at the University of Texas at Arlington (UTA) have made significant strides in understanding how cells remove waste, a finding that could pave the way for improved treatments for…
Merck’s Enlicitide Demonstrates Efficacy in Cholesterol Trial
The pivotal CORALreef Lipids study has shown that **enlicitide decanoate**, an oral PCSK9 inhibitor developed by **Merck**, successfully met all primary and key secondary endpoints for treating hypercholesterolemia in adults…